FDA Import Refusal 799-0609417-2/11/1 — SANDEEP KAUR
The FDA refused shipment 799-0609417-2/11/1 from SANDEEP KAUR (India) on September 26, 2022. The refused product falls under Drugs and Biologics — GLIMEPIRIDE (ANTI-DIABETIC). Cited charges: 118,75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- September 26, 2022
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61PDY31 GLIMEPIRIDE (ANTI-DIABETIC)
- Charges
- 118,75